LENZ Therapeutics, Inc.(LENZ) - 2025 Q4 - Annual Results

Financial Results - LENZ Therapeutics, Inc. reported preliminary, unaudited financial results for Q4 2025, ending December 31, 2025[4] - The financial results are subject to change upon completion of the company's accounting and annual audit procedures[4] - A press release detailing these results was issued on January 7, 2026[4] - The financial statements and additional disclosures are necessary for a complete understanding of the company's financial position[4] Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[3]